PHAGE COMPOSITIONS FOR ESCHERICHIA COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF

PHAGE THERAPY OF E COLI INFECTIONS

Antibacterial composition and uses thereof

ENGINEERED CHIMERIC ANTIMICROBIAL AGENTS AGAINST GRAM-POSITIVE BACTERIA

METHODS AND BIOLOGICAL SYSTEMS FOR DISCOVERING AND OPTIMIZING LASSO PEPTIDES

Sequence-specific antimicrobials by blocking DNA repair

CROP TREATMENT

THERAPEUTIC BACTERIOPHAGES

System for protein inactivation and recombinant phages for targeted bacterial killing, infection, biodetection, and as a means of protein extraction

MULTIMERIC PROTEINS FOR DETECTING A CARBOHYDRATE AND/OR TREATING A SIGLEC-MEDIATED DISORDER

Phage therapy of infections

Phage-Mediated Molecular Detection Methods and Related Aspects

Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, bacillus anthracis and yersinia pestis

Sequence-specific antimicrobials by blocking DNA repair

Anti-bacterial compositions and uses thereof

Modified peptides

PROTEIN VARIANTS FOR USE AS LIPID BILAYER-INTEGRATED NANOPORE, AND METHODS THEREOF

Phage therapy of infections

Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, and

IMPROVING SEQUENCE-SPECIFIC ANTIMICROBIALS BY BLOCKING DNA REPAIR

Lactococcus garvieae bacteriophage Lac-GAP-1 and use thereof in suppressing proliferation of lactococcus garvieae bacteria

Recombinase mutants

Chimeric antibacterial polypeptides

Non-replicative transduction particles and transduction particle-based reporter systems

Phage therapy of infections

ATYPICAL INTEINS

Phage therapy of pseudomonas infections

Designing a soluble full-length HIV-1 gp41 trimer

bacteriophage and uses thereof

Composition capable of improving stability of bacteriophage lysin proteins

Disulfide stabilized foldon polypeptides

Bacteriophage for biocontrol of and in the manufacturing or processing of foods

Protein and nucleic acid delivery vehicles, components and mechanisms thereof

In vitro and In vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine

In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine

Designing a soluble full-length HIV-1 gp41 trimer

Chimeric antibacterial polypeptides

Bacteriophage and its use for preventing proliferation of pathogenic bacteria

Method of producing bacteriophage preparations comprising purification using affinity chromatography

Protein and nucleic acid delivery vehicles, components and mechanisms thereof

Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof

Protein and nucleic acid delivery vehicles, components and mechanisms thereof

Chimeric Phage Tail Proteins and Uses Thereof

Novel Polypeptides Having Endolysin Activity and Uses Thereof

Phage resistance

Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests

Virulent phages to detect in foodstuffs and in food processing plants

Novel recombinant T4 phage particle containing HIV, H. pylori or cancer antigens and uses thereof

T4 bacteriophage bound to a substrate

Novel thermophilic proteins and the nucleic acids encoding them

Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin

Ribonuclease resistant RNA preparation and utilization

Virulent phages to control in foodstuffs and in food processing plants

Nucleic acid delivery and expression

Antimicrobial proteins from the SPO1 bacteriophage